Treatment of Paranasal Sinus Indolent Mucormycosis
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Objectives: Mucormycosis of the nasal cavity and paranasal sinuses is a rare but highly aggressive especially in patients with diabetes or immunosuppressed patients. However, chronic non invastive type of mucormycosis can be observed in immunocompetent patients. In this study, we investigated indolent mucormycosis cases and assessed the clinical and radiological outcomes of indolent mucormycosis of paranasal sinus in healthy patients treated by endoscopic sinus surgery (ESS) alone. Materials and Methods: A retrospective chart analysis of 9 patients with the diagnosis of indolent mucormycosis of paranasal sinus and treated by ESS between 2007 and 2017 was performed. The data were collected from the medical records: age, sex, clinical presentations, pre- and postoperative endoscopic findings, underyling diseases, pathology, pre- and postoperative radiological findings. Radiologic images were reviewd to assess the involved side and sinus, bony sinus wall changes. Results: The histopathologic findings revealed mucormycosis with broad, non-septated, right-angled hyphae. Although the diagnosis of mucormycosis, the patients were not any antifungal agents after surgery. There was no disease progression and recurrence. Conclusion: In the case of paranasal sinus mucormycosis, ESS alone is thought to be sufficient to the treatment for indolent cases in immunocompetent patients without evidence of preoperative computed tomography and endoscopic findings of invasion and antifungal treatment may not be necessary.
Abstract
Background and Objectives: Mucormycosis of the nasal cavity and paranasal sinuses is a rare but highly aggressive especially in patients with diabetes or immunosuppressed patients. However, chronic non invastive type of mucormycosis can be observed in immunocompetent patients. In this study, we investigated indolent mucormycosis cases and assessed the clinical and radiological outcomes of indolent mucormycosis of paranasal sinus in healthy patients treated by endoscopic sinus surgery (ESS) alone. Materials and Methods: A retrospective chart analysis of 9 patients with the diagnosis of indolent mucormycosis of paranasal sinus and treated by ESS between 2007 and 2017 was performed. The data were collected from the medical records: age, sex, clinical presentations, pre- and postoperative endoscopic findings, underyling diseases, pathology, pre- and postoperative radiological findings. Radiologic images were reviewd to assess the involved side and sinus, bony sinus wall changes. Results: The histopathologic findings revealed mucormycosis with broad, non-septated, right-angled hyphae. Although the diagnosis of mucormycosis, the patients were not any antifungal agents after surgery. There was no disease progression and recurrence. Conclusion: In the case of paranasal sinus mucormycosis, ESS alone is thought to be sufficient to the treatment for indolent cases in immunocompetent patients without evidence of preoperative computed tomography and endoscopic findings of invasion and antifungal treatment may not be necessary.
참고문헌 (18)
- Kim ST, "Successful treatment of invasive rhinopulmonary mucormycosis with an indolent presentation by combined medical and surgical therapy", J Craniofac Surg, 24(2), pp.e182~e184 (2013)
- Jung H, "Indolent mucormycosis of the paranasal sinus in immunocompetent patients : are antifungal drugs needed?", J Laryngol Otol, 127(9), pp.872~875 (2013)
- Bobey AB, "The changing face of paranasal sinus fungus balls", Ann Otol Rhinol Laryngol, 118(7), pp.500~505 (2009)
- Szalai G, "Mucormycosis mimicks sinusitis in a diabetic adult", Ann N Y Acad Sci, 1084(1), pp.520~530 (2006)
- Spellberg B, "Novel perspectives on mucormycosis : pathophysiology, presentation, and management", Clin Microbiol Rev, 18(3), pp.556~569 (2005)
- O’Neill BM, "Disseminated rhinocerebral mucormycosis : a case report and review of the literature", J Oral Maxillofac Surg, 64(2), pp.326~333 (2006)
- Dhiwakar M, "Improving outcomes in rhinocerebral mucormycosis-early diagnostic pointers and prognostic factors", J Laryngol Otol, 117(11), pp.861~865 (2003)
- Talmi YP, "Rhino-orbital and rhino-orbito-cerebral mucormycosis", Otolaryngol Head Neck Surg, 127(1), pp.22~31 (2002)
- Peterson KL, "Rhinocerebral mucormycosis : evolution of the disease and treatment options", Laryngoscope, 107(7), pp.855~862 (1997)
- Thajeb P, "Fatal strokes in patients with rhino-orbito-cerebral mucormycosis and associated vasculopathy", Scand J Infect Dis, 36(9), pp.643~648 (2004)
- Hussain S, "Rhinocerebral invasive mycosis : occurrence in immunocompetent individuals", Eur J Radiol, 20(2), pp.P151~P155 (1995)
- O’Brien TJ, "Rhinocerebral mucormycosis presenting as periorbital cellulitis with blindness : report of 2 cases", Clin Exp Neurol, 31, pp.68~78 (1994)
- Sponsler TA, "Ocular invasion in mucormycosis", Surv Opthalmol, 36(5), pp.P345~P350 (1992)
- Husain S, "Opportunistic mycelial fungal infections in organ transplant recipients : emerging importance of non-Aspergillus mycelial fungi", Clin Infect Dis, 37(2), pp.221~229 (2003)
- Petrikkos G, "Mucormycosis : ten-year experience at a tertiary-care center in Greece", Eur J Clin Microbiol Infect Dis, 22(12), pp.753~756 (2003)
- Ketenci I, "Indolent mucormycosis of the sphenoid sinus", Otolaryngol Head Neck Surg, 132(2), pp.341~342 (2005)
- Ferguson BJ, "Mucormycosis of the nose and paranasal sinuses", Otolaryngol Clin North Am, 33(2), pp.349~365 (2000)
- deShazo RD, "A new classification and diagnostic criteria for invasive fungal sinusitis", Arch Otolaryngol Head Neck Surg, 123(11), pp.1181~1188 (1997)
